| Literature DB >> 33393085 |
Selma Mujezinović Larsen1,2, Kjersti Ramstad1, Terje Terjesen2,3.
Abstract
AIM: To investigate the prevalence, characteristics, and risk factors of hip pain in adolescents with cerebral palsy (CP) and compare the findings with those of the same individuals 5 years earlier.Entities:
Year: 2021 PMID: 33393085 PMCID: PMC8048986 DOI: 10.1111/dmcn.14782
Source DB: PubMed Journal: Dev Med Child Neurol ISSN: 0012-1622 Impact factor: 5.449
Association between hip pain and hip migration percentage in 128 hips of 64 adolescents with cerebral palsy
| Migration % | Number of hips | Hip pain |
| |
|---|---|---|---|---|
| No hip pain | Hip pain | |||
| All hips | 128 | 86 | 42 | |
| <33 | 97 | 67 | 30 | 0.004 |
| 33–39 | 9 | 7 | 2 | |
| 40–49 | 5 | 4 | 1 | |
| 50–89 | 9 | 1 | 8 | |
| 90–100 | 8 | 7 | 1 | |
Three patients did not have available pelvic radiographs.
Figure 1Radiograph of a 14‐year‐old female with bilateral spastic cerebral palsy in Gross Motor Function Classification System level IV, showing severe subluxation and femoral head deformity of the left hip and marked pelvic obliquity. She had unilateral severe pain in her left hip (Child Health Questionnaire hip pain score 20).
Figure 2Radiograph of a 14‐year old female with bilateral spastic cerebral palsy in Gross Motor Function Classification System level V, with painless bilateral complete hip dislocation, deformity of the right femoral head, and no pelvic obliquity.
Association between hip pain and possible risk factors for hip pain in 67 adolescents with cerebral palsy
| Risk factor | No hip pain | Hip pain | Univariable | Multivariable |
|---|---|---|---|---|
| Age, y:mo, mean (SD) | 14:11 (1:6) | 14:2 (1:4) | 0.018 | 0.202 |
| Sex | ||||
| Female | 15 | 13 | 0.514 | |
| Male | 24 | 15 | ||
| Predominant movement disorder | ||||
| Spastic | 31 | 22 | 0.928 | |
| Dyskinetic | 8 | 6 | ||
| Ambulation | ||||
| GMFCS level III | 13 | 2 | 0.013 | 0.027 |
| GMFCS level IV | 11 | 6 | ||
| GMFCS level V | 15 | 20 | ||
| Hip surgery | ||||
| No | 14 | 6 | 0.202 | |
| Yes | 25 | 22 | ||
| ITB | ||||
| No | 31 | 21 | 0.664 | |
| Yes | 8 | 7 | ||
| Migration %, most displaced hip | ||||
| <50% | 33 | 20 | 0.004 | |
| 50–89% | 0 | 6 | ||
Data are number of participants, unless otherwise stated.
Multivariable logistic regression could not be computed because one of the categories contained no hips. GMFCS, Gross Motor Function Classification System; ITB, intrathecal baclofen.
Association between Child Health Questionnaire (CHQ) hip pain score and clinical and radiographic variables
| Variable | CHQ hip pain score | Univariable | Multivariable |
|---|---|---|---|
| Age | 0.044 | 0.267 | |
| Sex | |||
| Female | 73 (33.8) | 0.721 | |
| Male | 76 (32.5) | ||
| Predominant movement disorder | |||
| Spastic | 75 (33.5) | 0.849 | |
| Dyskinetic | 76 (31.3) | ||
| Ambulation | |||
| GMFCS level III | 96 (11.2) | 0.003 | 0.001 |
| GMFCS level IV | 82 (28.1) | ||
| GMFCS level V | 63 (35.9) | ||
| Hip surgery | |||
| No | 85 (27.0) | 0.120 | |
| Yes | 71 (34.4) | ||
| ITB | |||
| No | 76 (32.2) | 0.572 | |
| Yes | 71 (35.8) | ||
| Migration %, most displaced hip ( | |||
| <50% | 77 (32.1) | 0.002 | 0.005 |
| 50–89% | 33 (22.5) | ||
Data are mean (SD).
GMFCS, Gross Motor Function Classification System; ITB, intrathecal baclofen therapy.
Comparison between the present study and the previous study (5 years earlier) of the same cohort (67 patients)
| Variables | Present study | Previous study |
|
|---|---|---|---|
| Age, y:mo, mean (range) |
14:7 (12:0–17:0) |
9:6 (7:0–12:0) | |
| Hip pain, participants | 28 (42) | 18 (27) | 0.041 |
| Hip pain, all hips | 44 (33) | 22 (16) | 0.001 |
| CHQ hip pain score, mean (SD) | 75 (33) | N/A | |
| Hip surgery | 47 (70) | 41 (61) | 0.031 |
| ITB | 15 (24) | 10 (15) | 0.063 |
| Migration %, most displaced hip, mean (SD) | 36 (24) | 35 (22) | 0.577 |
Data are n (%) unless otherwise stated.
Total number of hips n=134.
Available for 64 participants. CHQ, Child Health Questionnaire; N/A, not available; ITB, intrathecal baclofen.